Cirrhotic liver enhancement on dual-phase helical CT: comparison with noncirrhotic livers in 146 patients.

OBJECTIVE The purpose of this study was to prospectively determine any differences in vascular and liver enhancement between patients with cirrhosis and patients without cirrhosis during both the arterial and portal venous phases on dual-phase helical CT. SUBJECTS AND METHODS Fifty-eight patients with histologically proven cirrhosis (group 1) and 88 without cirrhosis (group 2 = normal findings on CT, group 3 = metastases, group 4 = other liver diseases) underwent dual-phase helical CT of the liver. Attenuation values of liver and vessels were measured on unenhanced scans and on scans obtained during the arterial and portal venous phases. The mean enhancement values per time interval (5 sec) were determined. Results were analyzed taking into account various intrinsic patient parameters. RESULTS We found no statistically significant difference in terms of mean vascular enhancement and mean liver enhancement during the arterial imaging phase for each time interval among all the groups. The mean peak enhancement and mean liver enhancement during the portal venous phase were significantly lower in group 1 than in other groups. Time to peak enhancement was significantly delayed in group 1. CONCLUSION In spite of the hepatic arterial buffer response, mean liver enhancement during the arterial phase was not significantly different in patients with cirrhosis compared with patients without cirrhosis. Although portal vein enhancement did not differ significantly, enhancement of cirrhotic liver was significantly lower during the portal venous phase and delayed, presumably because of decreased peripheral portal perfusion. The contrast injection protocol may be tailored to optimize conspicuity of hypovascular tumor.

[1]  Yedy Israel,et al.  The Role of Hepatocyte Enlargement in Hepatic Pressure in Cirrhotic and Noncirrhotic Alcoholic Liver Disease , 2007, Hepatology.

[2]  W W Lautt,et al.  Quantitation of the hepatic arterial buffer response to graded changes in portal blood flow. , 1990, Gastroenterology.

[3]  T. Chambers,et al.  Hepatic CT enhancement: comparison of ionic and nonionic contrast agents in the same patients. , 1994, Radiology.

[4]  G. Dodd,et al.  Investigation of contrast enhancement in CT of the liver: the need for improved methods. , 1993, AJR. American journal of roentgenology.

[5]  R. Baron,et al.  Helical biphasic contrast-enhanced CT of the liver: technique, indications, interpretation, and pitfalls. , 1996, Radiology.

[6]  J. Ternberg,et al.  Blood-Flow Relation between Hepatic Artery and Portal Vein , 1965, Science.

[7]  K. Okuda,et al.  Portal venous hemodynamics in chronic liver disease: effects of posture change and exercise. , 1985, Radiology.

[8]  P Soyer,et al.  MR imaging of the liver: Effect of portal hypertension on hepatic parenchymal enhancement using a gadolinium chelate , 1997, Journal of magnetic resonance imaging : JMRI.

[9]  Y. Itai,et al.  Blood flow and liver imaging. , 1997, Radiology.

[10]  R. Baron,et al.  Understanding and optimizing use of contrast material for CT of the liver. , 1994, AJR. American journal of roentgenology.

[11]  M Takahashi,et al.  Multiple-phase helical CT of the liver for detecting small hepatomas in patients with liver cirrhosis: contrast-injection protocol and optimal timing. , 1996, AJR. American journal of roentgenology.

[12]  R. Pugh,et al.  Transection of the oesophagus for bleeding oesophageal varices , 1973, The British journal of surgery.

[13]  R C Nelson,et al.  Helical liver CT with computer-assisted bolus-tracking technology: is it possible to predict which patients will not achieve a threshold of enhancement? , 1998, Radiology.

[14]  B L Holbert,et al.  Hepatocellular carcinoma: evaluation with biphasic, contrast-enhanced, helical CT. , 1996, Radiology.

[15]  T Nakamura,et al.  Measurement of portal vascular resistance in patients with portal hypertension. , 1986, Gastroenterology.

[16]  A. Toyonaga,et al.  Hepatic artery hemodynamic responsiveness to altered portal blood flow in normal and cirrhotic livers. , 1996, Radiology.

[17]  T. Chambers,et al.  Hepatic CT enhancement. Part II. Alterations in contrast material volume and rate of injection within the same patients. , 1994, Radiology.

[18]  A K Dixon,et al.  Functional images of hepatic perfusion obtained with dynamic CT. , 1993, Radiology.

[19]  J J Brown,et al.  Imaging of hepatic cirrhosis. , 1997, Radiology.

[20]  P M Silverman,et al.  Assessment of a technology that permits individualized scan delays on helical hepatic CT: a technique to improve efficiency in use of contrast material. , 1996, AJR. American journal of roentgenology.